This is a review about Cdk4, based on 61 published articles (read how Labome selects the articles), using Cdk4 antibody in all methods. It is aimed to help Labome visitors find the most suited Cdk4 antibody.
Cdk4 synonym: CMM3; PSK-J3; cell division protein kinase 4

Santa Cruz Biotechnology
rabbit polyclonal (C-22)
  • WB; human
Santa Cruz Biotechnology Cdk4 antibody (santa cruz, sc-260) was used in western blot on human samples. Carcinogenesis (2015) ncbi
rabbit polyclonal (C-22)
  • WB; mouse; 1:1000
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz Biotechnology, sc-260) was used in western blot on mouse samples at 1:1000. Biochim Biophys Acta (2015) ncbi
rabbit polyclonal (C-22)
  • WB; human
In order to explore how Nek2 isoform A affects anaphase-promoting complex/cyclosome containing Cdc20, Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-260) was used in western blot on human samples. J Cell Sci (2015) ncbi
rabbit polyclonal (C-22)
  • WB; human
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz Biotechnology, sc-260) was used in western blot on human samples. Acta Biochim Biophys Sin (Shanghai) (2015) ncbi
goat polyclonal (C-22)
  • WB; human; fig 1
In order to identify CDK4 binding partners, Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, C-22) was used in western blot on human samples (fig 1). Cell Cycle (2014) ncbi
rabbit polyclonal (H-22)
  • WB; mouse
In order to identify the mechanistic link between Cullin neddylation and Myc ubiquitination/degradation, Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz Biotechnology, sc-601) was used in western blot on mouse samples. Nat Commun (2014) ncbi
rabbit polyclonal (C-22)
  • WB; human; 1:500-1:1000
In order to study the effect of imatinib on neuroblastoma cell lines, Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-260) was used in western blot on human samples at 1:500-1:1000. Biochem Pharmacol (2014) ncbi
rabbit polyclonal (C-22)
  • IHC; African green monkey; 1:40
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz Biotechnology, SC-260) was used in immunohistochemistry on African green monkey samples at 1:40. Endocrinology (2014) ncbi
mouse monoclonal (DCS-35)
  • WB; human
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz Biotechnology, sc-23896) was used in western blot on human samples. BMC Cancer (2014) ncbi
rabbit polyclonal (C-22)
  • WB; human
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, SC-260) was used in western blot on human samples. Antioxid Redox Signal (2015) ncbi
rabbit polyclonal (C-22)
  • WB; human
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz Technology, sc-260) was used in western blot on human samples. Mol Cancer (2014) ncbi
mouse monoclonal (B-10)
  • WB; human
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-166373) was used in western blot on human samples. Exp Cell Res (2014) ncbi
rabbit polyclonal (C-22)
  • WB; rat; 1:500
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-260) was used in western blot on rat samples at 1:500. PLoS ONE (2014) ncbi
rabbit polyclonal (C-22)
  • WB; human
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-260) was used in western blot on human samples. Cell Cycle (2013) ncbi
rabbit polyclonal (H-22)
  • WB; human
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-601) was used in western blot on human samples. Mol Cancer Res (2013) ncbi
rabbit polyclonal (C-22)
  • WB; human
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz Biotechnology, sc-260) was used in western blot on human samples. Nucleic Acids Res (2013) ncbi
rabbit polyclonal (C-22)
  • IC; mouse
  • WB; mouse
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz Biotechnology, sc-260) was used in immunocytochemistry on mouse samples and in western blot on mouse samples. Oncogene (2011) ncbi
rabbit polyclonal (C-22)
  • WB; human; fig 3
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-260) was used in western blot on human samples (fig 3). Clin Cancer Res (2010) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology mouse monoclonal anti-cdk4 antibody was used for western blot in order to investigate the role of Aurora B in the regulation of postmitotic endoreduplication checkpoint.Mol Biol Cell (2009) ncbi
not indicated
  • WB; human
Santa Cruz anti-CDK4 antibody was used to perform western blot in order to study the regulation of NANOG in G1 to S transition in human embryonic stem cells.J Cell Biol (2009) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology CDK4 antibody was used in western blot in order to show that Hsp90 co-chaperone CDC37 can maintain the oncogenic protein kinase clients.Oncogene (2009) ncbi
rabbit polyclonal (C-22)
  • WB; human
Santa Cruz Biotechnology CDK4 antibody (1:200 dilution) was used in western blot in order to study molecular mechanisms underlying TSH-secreting pituitary tumors (TSHomas)Endocrinology (2008) ncbi
not indicated
  • WB; human
Santa Cruz polyclonal rabbit anti-CDK4 was used in 1:500 dilution to perform western blot in order to show the mechanism of cancer cell proliferation and invasion inhibition by PCDGF/GEP blockadeBMC Cancer (2007) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology polyclonal anti-CDK4 antibody C-22 was used in human cells (T98G, IMR-90 cells) and in western blot to study the role for cyclins and CDK "inhibitors" in Thr172 phosphorylation of CDK4.Mol Cell Biol (2006) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology Cdk2 antibody was used in western blot to study the roles of ATF3 in both cell death and cell cycle regulation.J Biol Chem (2006) ncbi
not indicated
  • WB; human
SCBT anti-CDK4 (C-22) antibody was used in western blot to investigate the regulation of Cdc6 protein stability by p53.Mol Cell Biol (2005) ncbi
not indicated
  • IP; human
SCBT anti-CDK4 (C-22) antibody was used in immunoprecipitation to investigate the role of ORC2 in CDK2 activationJ Biol Chem (2005) ncbi
not indicated
  • WB; human
  • IP; human
Santa Cruz Biotechnology antibody against cdk4 (product C-22) was used in immunoprecipitation to isolate cdk4 and in western blot to detect cdk4 in human primary effusion lymphoma (PEL) cell line BC3J Natl Cancer Inst (2005) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnologies Cdk4 antibody was used in western blot to study COLO-357 cell growth inhibition by TGF beta1J Biol Chem (2005) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology rabbit polyclonal Cdk4 (C-22) antibody was used in western blot to study retinoblastoma phosphorylation in neuronal cell deathJ Cell Sci (2005) ncbi
rabbit polyclonal (C-22)
  • WB; human
Santa Cruz Biotechnology CDK4 antibody (1:100) was used in western blot to study the role of an unliganded TRbeta mutant in pituitary tumorigenesis in vivo.Mol Cell Biol (2005) ncbi
Invitrogen
mouse monoclonal (DCS-31)
  • IHC; human
In order to investigate the frequency and contribution of HMGA2, CDK4, and JUN to dedifferentiated liposarcomas and atypical lipomatous tumors/well-differentiated liposarcomas, Invitrogen Cdk4 antibody (Biosource International, DCS 31) was used in immunohistochemistry on human samples. Mod Pathol (2015) ncbi
mouse monoclonal (DCS-31)
  • IHC-P; human; 1:50
In order to characterize a primary myxoid liposarcoma with chondroid and osseous components, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:50. Appl Immunohistochem Mol Morphol (2015) ncbi
mouse monoclonal (DCS-31)
  • IHC-P; human; 1:200
Invitrogen Cdk4 antibody (Invitrogen, clone DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:200. Hum Pathol (2015) ncbi
mouse monoclonal (DCS-31)
  • IHC-P; human; 1:100
In order to determine the role and diagnostic efficacy of RB1, CDK4, CHMP2B, HSP90, and cPLA2G4A as markers in myxofibrosarcomas and myxoid liposarcomas, Invitrogen Cdk4 antibody (Life Technologies, DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:100. Int J Surg Pathol (2014) ncbi
mouse monoclonal (DCS-31)
  • IHC; human
In order to describe a woman showing an incidental hibernoma associated with a cortical adenoma producing primary hyperaldosteronism, Invitrogen Cdk4 antibody (Biosource International, DCS-31) was used in immunohistochemistry on human samples. Pathol Res Pract (2013) ncbi
mouse monoclonal (DCS-31)
  • IHC; human; 1:700; tbl 1
In order to report on a case of plexiform fibromyxoma of the stomach, Invitrogen Cdk4 antibody (Invitrogen, DCS-31) was used in immunohistochemistry on human samples at 1:700 (tbl 1). Int J Surg Pathol (2014) ncbi
mouse monoclonal (DCS-31)
  • IHC-P; human; 1:200
Invitrogen Cdk4 antibody (Invitrogen, DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:200. World Neurosurg (2014) ncbi
mouse monoclonal (DCS-31)
  • IHC; human; 1:250; fig 4
In order to study the clinicopathological and genetic features of well-differentiated/dedifferentiated liposarcoma with prominent myxoid stroma, Invitrogen Cdk4 antibody (Invitrogen, DCS-31) was used in immunohistochemistry on human samples at 1:250 (fig 4). Histopathology (2013) ncbi
mouse monoclonal (DCS-31)
  • IHC; human; fig 3
In order to assess if MDM2 copy number distinguishes lipomas from atypical lipomatous tumors, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry on human samples (fig 3). Mod Pathol (2012) ncbi
mouse monoclonal (DCS-31)
  • IHC-P; human; 1:200; tbl 1.
In order to discuss markers that distinguish between different subtypes of osteosarcomas, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 1.). Am J Surg Pathol (2012) ncbi
mouse monoclonal (DCS-31)
  • IC; human; 1:250; fig 8
In order to characterize malignant fat-forming solitary fibrous tumor, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunocytochemistry on human samples at 1:250 (fig 8). Am J Surg Pathol (2011) ncbi
mouse monoclonal (DCS-31)
  • IHC; human; 1:50; fig 6
In order to examine expression of MDM2-CDK4 in low-grade osteosarcomas and fibrous or fibro-osseous lesions of the bone or paraosseous soft tissue, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry on human samples at 1:50 (fig 6). Mod Pathol (2011) ncbi
mouse monoclonal (DCS-31 + DCS-35)
  • WB; rat; 1:100; fig 3
In order to study the mechanism of thrombin-induced apoptosis in cultured cortical neurons, Invitrogen Cdk4 antibody (Lab Vision, MS-616) was used in western blot on rat samples at 1:100 (fig 3). J Neurochem (2007) ncbi
not indicated
  • WB; human
NeoMarkers anti-Cdk4 antibody was used in human T-cell leukemia cell lines and in western blot to study the effect of Jak-Stat pathway on cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.Retrovirology (2006) ncbi
mouse monoclonal (DCS-31)
  • IHC-F; human; 1:200; fig 3
In order to characterize dedifferentiated liposarcomas with an inflammatory malignant fibrous histiocytoma component, Invitrogen Cdk4 antibody (Biosource International, clone DCS-31) was used in immunohistochemistry - frozen section on human samples at 1:200 (fig 3). J Pathol (2004) ncbi
mouse monoclonal (DCS-31)
  • IHC-P; human
In order to report that most so-called malignant fibrous histiocytomas from the retroperitoneum are dedifferentiated liposarcoma, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry - paraffin section on human samples. Mod Pathol (2003) ncbi
GeneTex
mouse monoclonal (DCS-31.2)
  • IHC; human; 1:50
GeneTex Cdk4 antibody (GeneTex, GTX75694) was used in immunohistochemistry on human samples at 1:50. Pathol Res Pract (2014) ncbi
EMD Millipore
not indicated
  • WB; human
Millipore anti-CDK4 antibody was used to perform western blot in order to study the roles of the fragile X mental retardation protein during the regulations of the proliferation and differentiation of adult neural stem/progenitor cells.PLoS Genet (2010) ncbi
not indicated
  • WB; human
Upstate Biotechnology cdk4 antibody was used in western blot to study the role of cdk5 in the regulation of breast cancer cell proliferation and apoptosis.Exp Mol Pathol (2007) ncbi
Cell Signaling Technology
mouse monoclonal (DCS156)
  • WB; human; fig 4
Cell Signaling Technology Cdk4 antibody (Cell Signaling, 2906) was used in western blot on human samples (fig 4). Drug Des Devel Ther (2015) ncbi
mouse monoclonal (DCS156)
  • WB; human
Cell Signaling Technology Cdk4 antibody (Cell Signaling, 2906) was used in western blot on human samples. Cell Cycle (2014) ncbi
mouse monoclonal (DCS156)
  • WB; human; 1:500
Cell Signaling Technology Cdk4 antibody (Cell Signaling, 2906) was used in western blot on human samples at 1:500. PPAR Res (2014) ncbi
  • WB; human
Cell Signalling Technolgies mouse anti-CDK4 antibody (catalog no:2906) was used in western blot to combine computational simulations, experimental testing of simulation results, and finally reverse engineering of a protein interaction network to define potential therapeutic strategies for de novo trastuzumab resistant breast cancerBMC Syst Biol (2009) ncbi
not indicated
  • WB; human
Cell Signaling Technology anti-phospho-specific-CDK4 (Thr172) antibody was used in human (T98G, IMR-90) cells and in western blot to study the role for cyclins and CDK "inhibitors" in Thr172 phosphorylation of CDK4.Mol Cell Biol (2006) ncbi
not indicated
  • WB; human
Cell Signaling anti-CDK4 antibody was used in western blot to study that tumor suppressor SMAR1 mediates Cyclin D1 repression by recruitment of the SIN3/Histone deacetylase 1 complex.Mol Cell Biol (2005) ncbi
not indicated
  • WB; human
Cell Signaling anti-CDK4 antibody was used in western blot to detect CDK4 in HT-29 cells treated with NMT1-1 siRNA or NMT2-4 siRNA.Mol Cancer Res (2005) ncbi
  • WB; human
Cell Signaling anti-Cdk4 (catalog no. 2906) antibody was used in western blot to study tumor necrosis factor alpha-dependent drug resistance to purine and pyrimidine analogues in human colon tumor cellsJ Biol Chem (2005) ncbi
BD Biosciences
mouse monoclonal (DCS-35)
  • WB; mouse
In order to demonstrate a novel role for Poldip2 in regulating the cell cycle, BD Biosciences Cdk4 antibody (BD, 559693) was used in western blot on mouse samples. PLoS ONE (2014) ncbi
mouse monoclonal (97/Cdk4)
  • WB; human; 1:500
In order to develop a neuregulin-1 overexpressing transgenic mouse model of neurofibroma-malignant peripheral nerve sheath tumor progression, BD Biosciences Cdk4 antibody (BD Biosciences, 610147) was used in western blot on human samples at 1:500. Am J Pathol (2013) ncbi
not indicated
  • WB; human
BD PharMingen anti-CDK4 antibody was used in western blot in order to demonstrate that sulindac suppresses beta-catenin expression in human cancer cellsEur J Pharmacol (2008) ncbi
Sigma-Aldrich
not indicated
  • WB; human
Sigma mouse anti-CDK4 antibody (C8218) was used in western blot to study the association of the chromatin remodelling factor BRG1 with the tumor suppressor p16INK4aMol Cancer (2009) ncbi
GE Healthcare Life Biosciences
not indicatedDharmacon CDK4 siRNA was used for RNAi in order to combine computational simulations, experimental testing of simulation results, and finally reverse engineering of a protein interaction network to define potential therapeutic strategies for de novo trastuzumab resistant breast cancerBMC Syst Biol (2009) ncbi
Articles Reviewed
  1. Christelle Lenain et al. (2015). "Autophagy-mediated degradation of nuclear envelope proteins during oncogene-induced senescence".PMID 26354777
  2. Esma Saâda-Bouzid et al. (2015). "Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas".PMID 26336885
  3. Kun Chun Chiang et al. (2015). "PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo".PMID 26316702
  4. Carla Cicchini et al. (2015). "Epigenetic control of EMT/MET dynamics: HNF4α impacts DNMT3s through miRs-29".PMID 26003733
  5. Noëlle Weingertner et al. (2015). "Myxoid liposarcoma with heterologous components: dedifferentiation or metaplasia? A FISH-documented and CGH-documented case report".PMID 25747531
  6. Alberto Righi et al. (2015). "MDM2 and CDK4 expression in periosteal osteosarcoma".PMID 25680902
  7. Michiel Boekhout et al. (2015). "Nek2A destruction marks APC/C activation at the prophase-to-prometaphase transition by spindle-checkpoint-restricted Cdc20".PMID 25673878
  8. Zhaoxia Niu et al. (2015). "Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells".PMID 25630654
  9. Siwanon Jirawatnotai et al. (2014). "The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis".PMID 25486477
  10. Jian Chen et al. (2014). "CSN6 drives carcinogenesis by positively regulating Myc stability".PMID 25395170
  11. Elisa Lupino et al. (2014). "Exposure of neuroblastoma cell lines to imatinib results in the upregulation of the CDK inhibitor p27(KIP1) as a consequence of c-Abl inhibition".PMID 25264277
  12. Adina Dumitrescu et al. (2014). "Placental estrogen suppresses cyclin D1 expression in the nonhuman primate fetal adrenal cortex".PMID 25247468
  13. Camila S Oliveira et al. (2014). "Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma".PMID 25168062
  14. Marrit Putker et al. (2015). "Evolutionary acquisition of cysteines determines FOXO paralog-specific redox signaling".PMID 25069953
  15. David I Brown et al. (2014). "Poldip2 knockout results in perinatal lethality, reduced cellular growth and increased autophagy of mouse embryonic fibroblasts".PMID 24797518
  16. Tao Wang et al. (2014). "Immunohistochemical analysis of expressions of RB1, CDK4, HSP90, cPLA2G4A, and CHMP2B is helpful in distinction between myxofibrosarcoma and myxoid liposarcoma".PMID 24788530
  17. Yan Wang et al. (2014). "The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy".PMID 24775809
  18. Marieke H van der Linden et al. (2014). "MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL".PMID 24736461
  19. Abhita Malaviya et al. (2014). "Synergistic Antiproliferative Effects of Combined γ -Tocotrienol and PPAR γ Antagonist Treatment Are Mediated through PPAR γ -Independent Mechanisms in Breast Cancer Cells".PMID 24729783
  20. João Agostinho Machado-Neto et al. (2014). "ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells".PMID 24726915
  21. Nimmi Baby et al. (2014). "Runx1t1 (Runt-related transcription factor 1; translocated to, 1) epigenetically regulates the proliferation and nitric oxide production of microglia".PMID 24586690
  22. Thomas Knösel et al. (2014). "Dedifferentiated chondrosarcoma mimicking a giant cell tumor. Is this low grade dedifferentiated chondrosarcoma?".PMID 24405942
  23. Jose Fernando Val-Bernal et al. (2013). "Incidental lipoma-like hibernoma arising from the adrenal gland: a well-differentiated liposarcoma mimicker".PMID 24002005
  24. Adeline C Ledoux et al. (2013). "NFκB regulates expression of Polo-like kinase 4".PMID 23974100
  25. Peter W T Lee et al. (2014). "Plexiform fibromyxoma (plexiform angiomyxoid myofibroblastic tumor) of stomach: an unusual presentation as a fistulating abscess".PMID 23794494
  26. Youssef Yakkioui et al. (2014). "A comparison of cell-cycle markers in skull base and sacral chordomas".PMID 23416769
  27. Syed J Kazmi et al. (2013). "Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis".PMID 23321323
  28. Gregor M Balaburski et al. (2013). "A modified HSP70 inhibitor shows broad activity as an anticancer agent".PMID 23303345
  29. Laurent Jullien et al. (2013). "Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response".PMID 23193277
  30. Stefano Sioletic et al. (2013). "Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases".PMID 23020289
  31. Takeshi Kashima et al. (2012). "Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor".PMID 22699518
  32. Akihiko Yoshida et al. (2012). "MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype".PMID 22301501
  33. Jen Chieh Lee et al. (2011). "Malignant fat-forming solitary fibrous tumor (so-called "lipomatous hemangiopericytoma"): clinicopathologic analysis of 14 cases".PMID 21716088
  34. Fanny Dujardin et al. (2011). "MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone".PMID 21336260
  35. R M H Fernández et al. (2011). "Cyclin D1 interacts and collaborates with Ral GTPases enhancing cell detachment and motility".PMID 21242975
  36. Gong Yang et al. (2010). "Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2".PMID 20423983
  37. Yuping Luo et al. (2010). "Fragile x mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells".PMID 20386739
  38. Jayasree S Nair et al. (2009). "Aurora B kinase regulates the postmitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780".PMID 19225156
  39. Therese M Becker et al. (2009). "The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a".PMID 19149898
  40. Xin Zhang et al. (2009). "A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A".PMID 19139263
  41. Ozgur Sahin et al. (2009). "Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance".PMID 19118495
  42. J R Smith et al. (2009). "Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors".PMID 18931700
  43. Changxue Lu et al. (2008). "Activation of phosphatidylinositol 3-kinase signaling promotes aberrant pituitary growth in a mouse model of thyroid-stimulating hormone-secreting pituitary tumors".PMID 18356276
  44. Anjia Han et al. (2008). "Sulindac suppresses beta-catenin expression in human cancer cells".PMID 18291362
  45. Yulan Liu et al. (2007). "Inhibition of PC cell-derived growth factor (PCDGF)/granulin-epithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK4 and inactivation of MMP-2".PMID 17261172
  46. Haripriya Vittal Rao et al. (2007). "Cyclin D1, cdk4, and Bim are involved in thrombin-induced apoptosis in cultured cortical neurons".PMID 17254021
  47. Shaun Goodyear et al. (2007). "Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5".PMID 17081516
  48. Laurence Bockstaele et al. (2006). "Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors"".PMID 16782892
  49. Mariko Tomita et al. (2006). "Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells".PMID 16603085
  50. Dan Lu et al. (2006). "Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis".PMID 16469745
  51. Shravanti Rampalli et al. (2005). "Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex".PMID 16166625
  52. Charles E Ducker et al. (2005). "Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis".PMID 16123142
  53. Anja Duursma et al. (2005). "p53-Dependent regulation of Cdc6 protein stability controls cellular proliferation".PMID 16055707
  54. Yuichi J Machida et al. (2005). "Acute reduction of an origin recognition complex (ORC) subunit in human cells reveals a requirement of ORC for Cdk2 activation".PMID 15944161
  55. Rukiyah Van Dross et al. (2005). "Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells".PMID 15870436
  56. Nichole Boyer Arnold et al. (2005). "Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein".PMID 15811853
  57. Malika Hamdane et al. (2005). "p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death".PMID 15741232
  58. Ling Chi Wang et al. (2005). "Tumor necrosis factor alpha-dependent drug resistance to purine and pyrimidine analogues in human colon tumor cells mediated through IKK".PMID 15611081
  59. Hiroko Furumoto et al. (2005). "An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis".PMID 15601836
  60. Jean Michel Coindre et al. (2004). "Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity".PMID 15221942
  61. Jean Michel Coindre et al. (2003). "Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma".PMID 12640106